- Home
- WOW vs PRTA Comparison
WOW vs PRTA Comparison
Compare WOW & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- PRTA
- Stock Information
- Founded
- WOW 2001
- PRTA 2012
- Country
- WOW United States
- PRTA Ireland
- Employees
- WOW N/A
- PRTA N/A
- Industry
- WOW Cable & Other Pay Television Services
- PRTA Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- PRTA Health Care
- Exchange
- WOW Nasdaq
- PRTA Nasdaq
- Market Cap
- WOW 285.5M
- PRTA 472.1M
- IPO Year
- WOW 2017
- PRTA N/A
- Fundamental
- Price
- WOW $5.09
- PRTA $8.20
- Analyst Decision
- WOW Hold
- PRTA Buy
- Analyst Count
- WOW 2
- PRTA 10
- Target Price
- WOW $5.20
- PRTA $14.86
- AVG Volume (30 Days)
- WOW 3.4M
- PRTA 1.2M
- Earning Date
- WOW 08-11-2025
- PRTA 08-04-2025
- Dividend Yield
- WOW N/A
- PRTA N/A
- EPS Growth
- WOW N/A
- PRTA N/A
- EPS
- WOW N/A
- PRTA N/A
- Revenue
- WOW $604,800,000.00
- PRTA $10,341,000.00
- Revenue This Year
- WOW N/A
- PRTA N/A
- Revenue Next Year
- WOW N/A
- PRTA $389.77
- P/E Ratio
- WOW N/A
- PRTA N/A
- Revenue Growth
- WOW N/A
- PRTA N/A
- 52 Week Low
- WOW $3.06
- PRTA $4.32
- 52 Week High
- WOW $5.79
- PRTA $22.83
- Technical
- Relative Strength Index (RSI)
- WOW 77.52
- PRTA 58.73
- Support Level
- WOW $5.06
- PRTA $8.05
- Resistance Level
- WOW $5.12
- PRTA $8.73
- Average True Range (ATR)
- WOW 0.03
- PRTA 0.38
- MACD
- WOW 0.03
- PRTA -0.05
- Stochastic Oscillator
- WOW 70.00
- PRTA 47.62
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.